Showing results (11-20 of 66) with videos related to
Sort By:
Pageof 7
Neuromuscular Disorders : NMD|June 2, 2015
Myasthenia gravis with presynaptic neurophysiological signs: Two case reports and literature reviewPaolo Emilio Alboini, Valentina Damato, Raffaele Iorio, et al.Journal of Neurology|January 2, 2021
Acetylcholine receptor antibody positivity rate in ocular myasthenia gravis: a matter of age?Gabriele Monte, Gregorio Spagni, Valentina Damato, et al.Bioengineering (Basel, Switzerland)|February 25, 2023
Hematopoietic Stem Cell Transplantation for the Treatment of Autoimmune Neurological Diseases: An UpdateAlice Mariottini, Giovanni Bulgarini, Sara Cornacchini, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|February 27, 2015
Neuromyelitis optica spectrum disorder as a paraneoplastic manifestation of lung adenocarcinoma expressing aquaporin-4Raffaele Iorio, Guido Rindi, Carmen Erra, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 5, 2021
Benefit and danger from immunotherapy in myasthenia gravisCarmelo Rodolico, Giulia Nicocia, Valentina Damato, et al.Journal of Neuroimmunology|November 26, 2025
Neurological adverse events of immune checkpoint inhibitors: A practical guide to diagnosis with a focus on neuroimaging findingsSimone Rossi, Alberto Vogrig, Laura Fionda, et al.European Journal of Neurology|January 9, 2021
Myasthenia gravis associated with anti-MuSK antibodies developed after SARS-CoV-2 infectionAndrea Assini, Ilaria Gandoglia, Valentina Damato, et al.International Journal of Molecular Sciences|July 29, 2025
CD20+ T Cells in Multiple Sclerosis: From Pathogenesis to Treatment-Induced DepletionAnna Chiara Mazzeo, Laura Calabresi, Valentina Damato, et al.Journal of Neuroimmunology|March 6, 2016
Disease specific enrichment of circulating let-7 family microRNA in MuSK+ myasthenia gravisTanel Punga, Emanuela Bartoccioni, Marta Lewandowska, et al.Journal of Neurology, Neurosurgery, and Psychiatry|October 25, 2022
Efficacy and safety of rituximab in myelin oligodendrocyte glycoprotein antibody-associated disorders compared with neuromyelitis optica spectrum disorder: a systematic review and meta-analysisGregorio Spagni, Bo Sun, Gabriele Monte, et al.Pageof 7